What is the best management approach for a 2-year-old pediatric patient with non-resolving Aerococcus urinae infection despite treatment with amoxicillin (amoxicillin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Aerococcus urinae UTI with Amoxicillin Failure in a 2-Year-Old

Switch to amoxicillin-clavulanate at high-dose (90 mg/kg/day of the amoxicillin component divided into 2 doses) for 7-14 days, as this provides β-lactamase coverage that may be needed for treatment failure while maintaining activity against Aerococcus urinae. 1, 2

Immediate Management Steps

Obtain Culture and Susceptibility Testing

  • Send a repeat urine culture with specific instructions to incubate in a CO2-containing atmosphere, as Aerococcus species require this environment for optimal growth and may be missed with standard culture techniques 3
  • Request antimicrobial susceptibility testing to guide definitive therapy, as treatment recommendations for Aerococcus urinae are primarily based on in vitro susceptibility patterns 4

Switch Antibiotic Therapy

  • Escalate to amoxicillin-clavulanate (co-amoxiclav) at 90 mg/kg/day of the amoxicillin component divided into 2 doses for a 2-year-old with treatment failure 1, 2
  • The β-lactamase inhibitor component addresses potential resistance mechanisms while maintaining coverage for Aerococcus urinae 2
  • Alternative dosing of 45 mg/kg/day divided into 3 doses is acceptable but twice-daily dosing at the higher dose improves compliance 1
  • Maximum daily dose should not exceed 4000 mg of amoxicillin 1

Treatment Duration

  • Treat for 7-14 days total, as recommended by the American Academy of Pediatrics for pediatric UTIs 1
  • Shorter courses (1-3 days) are inferior for febrile UTIs and should be avoided 1
  • While one case report showed success with 3 days of amoxicillin for uncomplicated Aerococcus urinae infection, this was in a patient without treatment failure 5

Alternative Antibiotic Options Based on Susceptibility

If Amoxicillin-Clavulanate Fails or Is Not Tolerated

  • Nitrofurantoin achieved clinical and microbiological success in 71%/76% of Aerococcus urinae UTI cases in adults, making it a reasonable alternative for cystitis (not pyelonephritis) 4
  • However, nitrofurantoin is inadequate for febrile UTI/pyelonephritis as it only achieves urinary concentrations 2
  • Pivmecillinam showed success in Aerococcus urinae cystitis cases 4
  • Ciprofloxacin was effective for pyelonephritis cases in the adult literature 4, though fluoroquinolones are generally avoided in pediatrics due to musculoskeletal safety concerns 2

For Severe or Invasive Infection

  • If the child appears toxic or has signs of pyelonephritis, consider parenteral therapy with ceftriaxone (50 mg/kg/dose every 24 hours) until clinical improvement occurs, typically within 24-48 hours 6, 1
  • For serious Aerococcus urinae infections, penicillin or ampicillin combined with an aminoglycoside has been recommended based on adult case series 7
  • One case of spondylodiscitis was successfully treated with amoxicillin for extended duration 8

Critical Evaluation Steps

Assess for Underlying Urological Abnormalities

  • Obtain a renal ultrasound to evaluate for anatomic abnormalities, as recommended for first febrile UTI in children <3 years 2
  • The one pediatric case report of Aerococcus urinae UTI revealed underlying bilateral mild to moderate hydronephrosis 5
  • Aerococcus urinae infections typically occur in patients with underlying urinary tract disorders 3, 7

Clinical Reassessment

  • Reassess at 24-48 hours to confirm fever resolution and clinical improvement 2
  • Adjust antibiotics based on culture results and susceptibilities when available 2
  • If symptoms persist beyond 48-72 hours on appropriate therapy, consider imaging to evaluate for complications such as renal abscess

Important Caveats

Avoid These Common Pitfalls

  • Do not use azithromycin or other macrolides, as they have inadequate coverage for common UTI pathogens and increasing resistance patterns 2
  • Do not use oral third-generation cephalosporins as monotherapy due to pneumococcal resistance patterns, though they may be considered as alternatives (cefixime 8 mg/kg/day, cefpodoxime 10 mg/kg/day divided into 2 doses) 1, 6
  • Do not assume standard urine culture techniques will detect Aerococcus species - specifically request CO2 incubation 3

Special Considerations for This Age Group

  • At age 2, the child is old enough that observation without antibiotics is not appropriate once bacterial UTI is confirmed 6
  • Local antimicrobial sensitivity patterns should guide empiric therapy choices 1
  • The rarity of Aerococcus urinae in pediatrics (only a few case reports exist) means treatment recommendations are extrapolated from adult data and in vitro susceptibility testing 5, 4

References

Guideline

Pediatric UTI Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Treatment for Concurrent Tonsillitis and UTI in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Three cases of serious infection caused by Aerococcus urinae.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1999

Research

Spondylodiscitis due to Aerococcus urinae: a first report.

Scandinavian journal of infectious diseases, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.